Understanding calcified coronary artery disease, its risk factors, symptoms, diagnosis, treatment, and prevention for a ...

New research has found that lower "bad" cholesterol and higher fat-transport markers are associated with a lower risk of ...

Despite major treatment advances, women make up less than 30 per cent of participants in clinical trials worldwide - undermining evidence-based care ...

A substantial proportion of patients with rheumatoid arthritis have abnormal FIB-4 index values, indicating a risk for liver ...

Novo Nordisk has announced plans to move its ziltivekimab into phase 3 clinical development in atherosclerosis with chronic kidney disease after a mid-stage trial met its main goal. The Danish ...